Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Norwegian-Danish Procurement Deal Targets Biogen’s Spinraza

Executive Summary

Norway and Denmark have signed an agreement for the joint procurement of medicines and have their eye on securing a lower price for Biogen’s orphan drug Spinraza.

You may also be interested in...



Biogen Pours Cold Water On Cross Country Spinraza Pricing Talks With Norway And Denmark

Biogen is reluctant to enter joint talks with Norway and Denmark over Spinraza, but the company expects that  cross-country pricing and reimbursement collaboration will become a fixture.

Nordic Procurement Deal Signals New Weapons In Fight For Lower Prices

A new joint procurement agreement between Norway and Denmark is a signal to drug companies that they will have to increasingly negotiate with more than one country in a new age of collaboration, says Amgros, the Danish medicines procurement agency.

Biogen: BeNeLuxA Spinraza Talks “Collaborative And Constructive" But Not Without Challenges

Biogen, the first company to win a positive reimbursement decision from the BeNeLuxA groups, says the process was “constructive and collaborative.” However, differences in local laws mean there will initially be some differences in coverage.

Topics

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel